I think they're closer to an acquisition then they are to being acquired. After approval I'd not be surprised if they try to acquire Oncovir, or rights to Poly-ICLC, for stock at the much higher price our stock should be selling at.
It would be a steal to get NWBO for $5 billion, but a few years from now it could attract $50 billion. I'd rather wait and watch the company grow in value.
It all starts with UK approval, it will happen, but only they can say when.
Gary
Market Data 
Markets 
AI
